Incyte Corporation Wins FDA Approval for Jakafi XR
WILMINGTON, Del., May 1, 2026 Incyte Corporation has secured U.S. Food and Drug Administration (FDA) approval for Jakafi XR™...
Prescription, Generic, and Over-The-Counter: Drugs & Products.
Arvinas Inc Gains FDA Approval for VEPPANU PROTAC Drug
NEW HAVEN, Conn., May 1, 2026 Arvinas, Inc., in collaboration with Pfizer Inc., announced that the U.S. Food and...
Rhythm Pharmaceuticals Secures EU Approval for IMCIVREE
BOSTON, MA, May 1, 2026 Rhythm Pharmaceuticals, Inc. announced that the European Commission has granted marketing authorization for IMCIVREE®...
Vanda Launches NEREUS First Motion Sickness Drug
Washington, United States | May 1, 2026 Vanda Pharmaceuticals Inc. has announced the U.S. commercial availability of NEREUS™ (tradipitant),...
Eton Pharmaceuticals Relaunches HEMANGEOL for Infants
DEER PARK, Illinois, May 1, 2026 Eton Pharmaceuticals, Inc. announced the relaunch of HEMANGEOL® (propranolol) oral solution, the only...
Viatris Low-Dose Estrogen Patch Phase 3 Data Update
Pittsburgh, USA | May 1, 2026 Viatris has announced multiple clinical data presentations for its investigational low-dose estrogen combined...
Apotex Gains Canada Approval for Generic Ozempic
Toronto, Canada | May 1, 2026 Apotex has received Health Canada approval for Apo-Semaglutide Injection™, a generic equivalent of...
Keenova TERLIVAZ Real-World Data Advances HRS-AKI Care
Dublin, Ireland | May 1, 2026 Keenova Therapeutics has announced new real-world clinical analysis of TERLIVAZ® (terlipressin) for hepatorenal...
AstraZeneca TRUQAP Gains FDA Panel Support in Prostate Cancer
WASHINGTON, D.C., April 30, 2026 AstraZeneca announced that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC)...
BeOne Medicines Gains FDA Priority Review for TEVIMBRA
SAN CARLOS, CALIFORNIA, April 29, 2026 BeOne Medicines has announced that the U.S. Food and Drug Administration (FDA) has...